Last updated: 10 July 2020 at 9:19pm EST

Robert Berman Net Worth




The estimated Net Worth of Robert Berman is at least $17.1 Million dollars as of 8 July 2020. Mr. Berman owns over 58,404 units of Biohaven Ltd stock worth over $2,098,371 and over the last 8 years he sold BHVN stock worth over $14,492,780. In addition, he makes $521,060 as Lead - Special Projects and Medical Oversight at Biohaven Ltd.

Mr. Berman BHVN stock SEC Form 4 insiders trading

Robert has made over 17 trades of the Biohaven Ltd stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 58,404 units of BHVN stock worth $35,626 on 8 July 2020.

The largest trade he's ever made was selling 160,000 units of Biohaven Ltd stock on 9 November 2017 worth over $4,121,600. On average, Robert trades about 39,641 units every 61 days since 2017. As of 8 July 2020 he still owns at least 58,745 units of Biohaven Ltd stock.

You can see the complete history of Mr. Berman stock trades at the bottom of the page.





Robert Berman biography

Robert Berman M.D. serves as Lead - Special Projects and Medical Oversight of the Company. Prior to this, from November 2015 to August 2019, he served as chief medical officer. From December 2013 to November 2015, he served as president of Biohaven Medical Services LLC and, prior to that, served as a group director of global clinical research at BMS from September 2003 to November 2013. Prior to his time at BMS, Dr. Berman was an associate director of clinical sciences, early development at Pfizer from November 2000 to September 2003. Since October 2012, Dr. Berman has also continued to serve as an adjunct professor of psychiatry at Yale University School of Medicine. Dr. Berman received his B.A. in molecular biophysics and biochemistry from Yale University and his M.D. from Mount Sinai School of Medicine of New York University.

What is the salary of Robert Berman?

As the Lead - Special Projects and Medical Oversight of Biohaven Ltd, the total compensation of Robert Berman at Biohaven Ltd is $521,060. There are 14 executives at Biohaven Ltd getting paid more, with Vlad Coric having the highest compensation of $6,787,630.



How old is Robert Berman?

Robert Berman is 57, he's been the Lead - Special Projects and Medical Oversight of Biohaven Ltd since 2019. There are 6 older and 8 younger executives at Biohaven Ltd. The oldest executive at Biohaven Ltd is Julia Gregory, 67, who is the Independent Director.

What's Robert Berman's mailing address?

Robert's mailing address filed with the SEC is C/O BIOHAVEN PHARMACEUTICALS, INC., 215 CHURCH STREET, NEW HAVEN, CT, 06510.

Insiders trading at Biohaven Ltd

Over the last 7 years, insiders at Biohaven Ltd have traded over $8,186,598,135 worth of Biohaven Ltd stock and bought 8,852,002 units worth $137,738,037 . The most active insiders traders include Robert J Hugin, John W Childs, and Declan Doogan. On average, Biohaven Ltd executives and independent directors trade stock every 14 days with the average trade being worth of $2,840,776. The most recent stock trade was executed by John W Childs on 18 July 2024, trading 28,400 units of BHVN stock currently worth $1,013,028.



What does Biohaven Ltd do?



Complete history of Mr. Berman stock trades at Biohaven Ltd

Insider
Trans.
Transaction
Total value
Robert Berman
Special Projects and Med Ovrsght
Option $35,626
8 Jul 2020
Robert Berman
Special Projects and Med Ovrsght
Option $2,621
23 Jun 2020
Robert Berman
Special Projects and Med Ovrsght
Option $162,603
18 Jun 2020
Robert Berman
Special Projects and Med Ovrsght
Option $76,250
30 Dec 2019
Robert Berman
Special Projects and Med Ovrsght
Option $32,581
18 Dec 2019
Robert Berman
Special Projects and Med Ovrsght
Buy $105,750
27 Jun 2019
Robert Berman
Special Projects and Med Ovrsght
Sale $3,783,951
8 Jun 2018
Robert Berman
Special Projects and Med Ovrsght
Sale $930,678
5 Jun 2018
Robert Berman
Special Projects and Med Ovrsght
Sale $938,700
10 May 2018
Robert Berman
Special Projects and Med Ovrsght
Sale $863,100
10 Apr 2018
Robert Berman
Special Projects and Med Ovrsght
Sale $1,053,850
12 Mar 2018
Robert Berman
Special Projects and Med Ovrsght
Sale $1,064,700
12 Feb 2018
Robert Berman
Special Projects and Med Ovrsght
Sale $963,200
10 Jan 2018
Robert Berman
Special Projects and Med Ovrsght
Sale $241,000
19 Dec 2017
Robert Berman
Special Projects and Med Ovrsght
Sale $532,000
11 Dec 2017
Robert Berman
Special Projects and Med Ovrsght
Sale $4,121,600
9 Nov 2017
Robert Berman
Special Projects and Med Ovrsght
Buy $850
9 May 2017


Biohaven Ltd executives and stock owners

Biohaven Ltd executives and other stock owners filed with the SEC include: